ロード中...
Regression of Crizotinib-Associated Complex Cystic Lesions after Switching to Alectinib
Crizotinib, which is effective in patients with anaplastic lymphoma kinase (ALK) positive non-small cell lung cancer, is sometimes associated with the generation of complex renal cysts. A 56-year-old man with ALK positive adenocarcinoma received crizotinib. Ten months after the introduction of crizo...
保存先:
| 出版年: | Intern Med |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
The Japanese Society of Internal Medicine
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5635307/ https://ncbi.nlm.nih.gov/pubmed/28794366 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2169/internalmedicine.8445-16 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|